Status:
NOT_YET_RECRUITING
Study on AUNIP as a Novel Tumor Marker for Cervical Cancer
Lead Sponsor:
Lin Yuan
Conditions:
Cervical Cancer
Eligibility:
FEMALE
20-60 years
Brief Summary
To detect the expression of AUNIP in cervical cancer serum, and to clarify its diagnostic and prognostic value.
Detailed Description
Blood of all study participants of cervical cancer patients are collected to detect the expression of AUNIP, analyze the statistical correlation between the expression of cervical cancer AUNIP and cli...
Eligibility Criteria
Inclusion
- Study group inclusion criteria:
- Women aged 20-60
- There is a definite pathological diagnosis of cervical cancer
- Healthy control group:
- Women aged 20-60
- No tumors in the uterus or other parts of the body
- No inflammatory disease
- Blood routine and blood biochemical tests are normal
Exclusion
- Exclusion criteria of the study group:
- There are other lesions in the uterus and uterine adnexa
- Exclusion criteria of healthy control group:
- Pregnant, lactating or menarche women
- Women who are undergoing human papillomavirus (HPV) vaccination
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2029
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06118463
Start Date
January 1 2024
End Date
January 1 2029
Last Update
November 9 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.